Drugs & Targets Huyabio International and BMS to collaborate on melanoma clinical April 02, 2021Vol.47 No.13
Drugs & Targets European Commission approves Cabometyx + Opdivo for first-line advanced renal cell carcinoma April 02, 2021Vol.47 No.13
Drugs & Targets Copiktra receives Positive CHMP Opinion for relapsed and refractory CLL and refractory FL April 02, 2021Vol.47 No.13
Conversation with The Cancer Letter Targeted therapies and better outcomes for small cell lung cancer? NCI study on actionable germline mutations finds a link March 26, 2021Vol.47 No.12By Matthew Bin Han Ong
In Brief Amy Abernethy to resign as principal deputy commissioner, acting CIO of FDA March 26, 2021Vol.47 No.12
In Brief John Byrd named chair of University of Cincinnati Department of Internal Medicine March 26, 2021Vol.47 No.12
